Achieve Life Sciences Inc. (NASDAQ: ACHV) Stock Information | RedChip

Achieve Life Sciences Inc. (NASDAQ: ACHV) Listen to this Section


$4.42
+0.0400 ( +0.91% ) 77.6K

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

Market Data


Open


$4.42

Previous close


$4.38

Volume


77.6K

Market cap


$152.82M

Day range


$4.36 - $4.54

52 week range


$3.03 - $5.98

Insider Ownership Transactions

Total Amount Purchased: -329,375.00 | $ -1,455,837.50

Date Type Amount Purchased Purchaser
2024-04-23 Sale -5625.00 Wan Jerry
2024-04-23 Sale -25000.00 Bencich John
2024-04-23 Sale -22500.00 Stewart Richard Alistair
2024-04-23 Sale -16250.00 JACOBS CINDY
2024-03-06 Buy 10000.00 Bencich John
2024-03-06 Buy 10000.00 Stewart Richard Alistair
2024-01-29 Sale -31500.00 Martell Bridget A
2024-01-24 Sale -84000.00 JACOBS CINDY
2024-01-24 Sale -140000.00 Stewart Richard Alistair
2024-01-24 Sale -24500.00 Wan Jerry

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 13 Aug 13, 2024
10-q Quarterly Reports 63 Aug 13, 2024
8-k 8K-related 13 Jul 29, 2024
8-k 8K-related 11 Jun 27, 2024
8-k 8K-related 11 Jun 06, 2024
10-q Quarterly Reports 60 May 09, 2024
8-k 8K-related 13 May 09, 2024
ars Annual reports 1 Apr 26, 2024
def Proxies and info statements 7 Apr 26, 2024
4 Insider transactions 1 Apr 23, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.